Caplyta 42 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB26FM8RA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,018
Award facts
- Contract value 100% obligated
- $3,018.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,018.19 to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of October 15, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen leverages its comprehensive IDC to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. CAPLYTA, a psychiatric medication used in the treatment of schizophrenia and bipolar disorder, represents one of the specialized pharmaceutical commodities within the company's extensive portfolio of brand-name drugs, generics, vaccines, and medical supplies delivered to the Defense Health Agency and other government healthcare systems. The company's federal contract performance demonstrates consistent capability to meet procurement requirements through open competition across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FM8RA?
SPE2DB26FM8RA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 14, 2025.
How much is contract SPE2DB26FM8RA worth?
The government has obligated $3,018 on SPE2DB26FM8RA.
Is contract SPE2DB26FM8RA an order under another contract?
Yes. SPE2DB26FM8RA is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB26FM8RA competed?
The extent of competition for SPE2DB26FM8RA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award